Launch of the Neuro-GD Study

June 21st, 2019

Dr Andy Stanfield is pleased to announce the launch of the Neuro-GD study which aims to better understand the clinical features of people with genetic conditions associated with intellectual disability and autism.  The initial focus is on SYNGAP1 related intellectual disability and fragile X syndrome but more conditions will be added. For more information click here.

Statin may be used to treat Fragile X Syndrome

June 9th, 2019

Co-Director of the Patrick Wild Centre Professor Peter Kind and colleagues have recently published a study showing that a drug named lovastatin, which is commonly used to lower cholesterol, corrected learning and memory problems in rats with a form of Fragile X Syndrome. Rats were treated with the drug for four weeks during infancy, but the benefits persisted for months afterwards. Fragile X Syndrome is one of the most common genetic causes of intellectual disability, and is often associated with …

Researcher in Spotlight – Stuart Cobb

August 9th, 2018

in our website feature “Researcher in Spotlight” this month we ask our researcher Stuart Cobb to tell us a bit more about himself Could you give us a quick overview of your background and career so far? I graduated in Pharmacology from the University of Glasgow, having studied the first part of my degree at Queen’s University, Canada. I then moved to the University of Oxford to conduct early studies on the role of interneurons in brain oscillations. I continued …